Swine flu program faces legal hurdles from vaccine makers
Government officials warn the swine flu vaccination plan for 2.5 million Americans could stall due to liability and insurance problems. Parke-Davis cancels spinal flu coverage, Wyeth and Merck struggle for adequate insurance, Merrell National threatens withdrawal without indemnity.
MENTIONED IN THIS ARTICLE
Washington
Parke, Davis & Co
Natibr
Ich
U.S
Wyeth Laboratories
Philadelphia
Merck Sharp & Dohme
Rahway
N.J
Merrell National Laboratories
Parke-Davis
Delano Meriwether
E. Burke Giblin
Warner-Lambert Co
Ford
Congressional Health
Public Health Service
Giblin
HEW
Senate Appropriations Committee
Ft. Dix
George Galasso
National Institute of Allergy and Infectious Diseases
Also Mentioned on This Page
Federal Advisory Committee On
Advertising Council Inc
Sidney M. Wolfe
Ralph Nader
Nition Casual Shop
Lefora Rire Ges
Mark
L.E.D
Golda
Fen
Our
Sander
Medhal
S. S Kresge Company
Schick
Kim
Losey Blvd
Hwy
the Nuclear Navy
Navy
North Broadway
Milwaukee
Wis